Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Papa

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Organic Chemistry|February 10, 2007
Template effects in the formation of [2]pseudo-rotaxanes containing diazapyrenium unitsGiancarlo Doddi, Gianfranco Ercolani, Paolo Mencarelli, et al.
Cardiovascular Diabetology|January 22, 2013
Macrovascular complication phenotypes in type 2 diabetic patientsGiuseppe Papa, Claudia Degano, Maria P Iurato, et al.
Diabetes Research and Clinical Practice|September 14, 2023
Glycometabolic outcomes in adult type 1 diabetic patients switching to closed-loop systemsGiuseppe Papa, Rossella Cannarella, Rosita A Condorelli, et al.
International Archives of Allergy and Immunology|October 31, 2002
Diagnosing nonimmediate reactions to penicillins by in vivo testsAntonio Romano, Marinella Viola, Chiara Mondino, et al.
Acta Diabetologica|January 26, 2012
Factors that influence basal insulin requirement in type 2 diabetesGiuseppe Papa, Roberto Baratta, Vincenzo Calì, et al.
Diabetes Care|July 29, 2006
Safety of type 2 diabetes treatment with repaglinide compared with glibenclamide in elderly people: A randomized, open-label, two-period, cross-over trialGiuseppe Papa, Viviana Fedele, Maria Rosaria Rizzo, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 5, 2023
Dapagliflozin improves erectile dysfunction in patients with type 2 diabetes mellitus: An open-label, non-randomized pilot studyRossella Cannarella, Rosita A Condorelli, Claudia Leanza, et al.
Biomedicines|May 27, 2026
Transitioning to Omnipod 5<sup>®</sup>: Effectiveness, Safety, and Patient-Reported Outcomes of a Tubeless Automated Insulin Delivery System in Adults with Type 1 Diabetes MellitusCarmelo Gusmano, Rossella Cannarella, Concetta Finocchiaro, et al.
Journal of Diabetes and Its Complications|March 4, 2025
Impact of automated insulin delivery (AID) systems on quality of life (QoL): Validation of the AID-QoL questionnaireGiuseppe Papa, Rossella Cannarella, Concetta Finocchiaro, et al.
Diabetes Research and Clinical Practice|September 11, 2025
Effect of daily insulin delivery variability on glycemic outcomes in patients with type 1 diabetes mellitus using an automated insulin delivery systemGiuseppe Papa, Rossella Cannarella, Carmelo Gusmano, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Organic Chemistry|February 10, 2007
Template effects in the formation of [2]pseudo-rotaxanes containing diazapyrenium unitsGiancarlo Doddi, Gianfranco Ercolani, Paolo Mencarelli, et al.
Cardiovascular Diabetology|January 22, 2013
Macrovascular complication phenotypes in type 2 diabetic patientsGiuseppe Papa, Claudia Degano, Maria P Iurato, et al.
Diabetes Research and Clinical Practice|September 14, 2023
Glycometabolic outcomes in adult type 1 diabetic patients switching to closed-loop systemsGiuseppe Papa, Rossella Cannarella, Rosita A Condorelli, et al.
International Archives of Allergy and Immunology|October 31, 2002
Diagnosing nonimmediate reactions to penicillins by in vivo testsAntonio Romano, Marinella Viola, Chiara Mondino, et al.
Acta Diabetologica|January 26, 2012
Factors that influence basal insulin requirement in type 2 diabetesGiuseppe Papa, Roberto Baratta, Vincenzo Calì, et al.
Diabetes Care|July 29, 2006
Safety of type 2 diabetes treatment with repaglinide compared with glibenclamide in elderly people: A randomized, open-label, two-period, cross-over trialGiuseppe Papa, Viviana Fedele, Maria Rosaria Rizzo, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 5, 2023
Dapagliflozin improves erectile dysfunction in patients with type 2 diabetes mellitus: An open-label, non-randomized pilot studyRossella Cannarella, Rosita A Condorelli, Claudia Leanza, et al.
Biomedicines|May 27, 2026
Transitioning to Omnipod 5<sup>®</sup>: Effectiveness, Safety, and Patient-Reported Outcomes of a Tubeless Automated Insulin Delivery System in Adults with Type 1 Diabetes MellitusCarmelo Gusmano, Rossella Cannarella, Concetta Finocchiaro, et al.
Journal of Diabetes and Its Complications|March 4, 2025
Impact of automated insulin delivery (AID) systems on quality of life (QoL): Validation of the AID-QoL questionnaireGiuseppe Papa, Rossella Cannarella, Concetta Finocchiaro, et al.
Diabetes Research and Clinical Practice|September 11, 2025
Effect of daily insulin delivery variability on glycemic outcomes in patients with type 1 diabetes mellitus using an automated insulin delivery systemGiuseppe Papa, Rossella Cannarella, Carmelo Gusmano, et al.
Pageof 2